Toronto, ON / ACCESSWIRE / December 5, 2018 / Eviana Health Corporation (the "Company") announces that effective November 30, 2018, Michael Galloro has resigned as a director of the Company.
Management and the board of directors would like to thank Mr. Galloro for his contributions to the Company.
About Eviana Health Corporation
Eviana Health Corporation is a Canadian Securities Exchange listed organization, which is in the business of producing and selling high quality cannabidiol ("CBD") targeting the medical, beauty & grooming, vitamins & supplements, fitness, food & beverage, and pet markets, through its operations in Serbia.
For further information, please contact:
Eviana Health Corporation:
Avram Adizes, Chief Executive Officer
Alexander Kotyck, President
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors - including the availability of funds, consummation of definitive documentation, the results of financing efforts, crop yields, the timing of operation of equipment - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE: Eviana Health Corporation